Kenny will be responsible for leading the global spinal implants, motion preservation, bone growth therapies and biologics businesses.
“Kevin is uniquely qualified to take on this role given his prior leadership experience in the spine and medical device business,” president and CEO Jon Serbousek said in a news release. “I look forward to the strategic guidance and expertise he will bring to our organization. Under his leadership, we will continue to deepen our commitment to transforming and accelerating our global spine business.”
Prior to joining Orthofix, Kenny held a number of leadership positions, including VP of U.S. sales at Medtronic Spine and Biologics and chief operating officer of Cardiovascular Systems. He also held leadership roles within Bausch and Lomb and B. Braun/McGaw.
“I am honored and excited to take on this leadership role with Orthofix Spine,” Kenny said. “I look forward to working with the spine team to grow our global footprint, and partner with our customers to ensure that our products and services meet their needs.”